Login / Signup

Meta-analysis of Association between Newer Glucose-Lowering Drugs and Risk of Parkinson's Disease.

Huilin TangYing LuMichael S OkunWilliam T DonahooAdolfo Ramirez-ZamoraFei WangYu HuangWei-Han ChenBeth A VirnigJiang BianSerena Jingchuan Guo
Published in: Movement disorders clinical practice (2023)
Newer GLDs may possibly be associated with a decreased risk of PD; however, larger datasets are required to confirm or refute this notion.
Keyphrases
  • systematic review
  • meta analyses
  • blood glucose
  • rna seq
  • case control
  • metabolic syndrome
  • adipose tissue
  • drug induced
  • single cell
  • glycemic control